InsiderClue
Insiders · Profile

Poulton Stuart

EVP, Chief Development Officer at Karyopharm Therapeutics. Filing since 15 Feb 2023. CIK 0001942597

Company
Date
Role
Action
Shares
Amount
Of holding
KPTI Karyopharm Therapeutics Inc.
28 Jul 2026
EVP, Chief Development Officer
Sold at will
189
$1.34K
0.2%
KPTI Karyopharm Therapeutics Inc.
14 May 2026
EVP, Chief Development Officer
Sold at will
403
$3.83K
0.4%
KPTI Karyopharm Therapeutics Inc.
2 Mar 2026
EVP, Chief Development Officer
Sold at will
5,101
$48.00K
5.1%
KPTI Karyopharm Therapeutics Inc.
17 Feb 2026
EVP, Chief Development Officer
Sold at will
378
$3.26K
0.4%
KPTI Karyopharm Therapeutics Inc.
15 Sep 2025
EVP, Chief Development Officer
Sold at will
401
$2.58K
1.4%
KPTI Karyopharm Therapeutics Inc.
29 Jul 2025
EVP, Chief Development Officer
Sold at will
191
$834.67
0.7%
KPTI Karyopharm Therapeutics Inc.
4 Mar 2025
EVP, Chief Development Officer
Sold at will
3,548
$22.32K
11.5%
KPTI Karyopharm Therapeutics Inc.
18 Feb 2025
EVP, Chief Development Officer
Sold at will
5,914
$3.73K
1.8%
KPTI Karyopharm Therapeutics Inc.
30 Jul 2024
EVP, Chief Development Officer
Sold at will
2,883
$3.06K
0.9%
KPTI Karyopharm Therapeutics Inc.
1 Mar 2024
EVP, Chief Development Officer
Sold at will
6,155
$7.39K
1.8%
KPTI Karyopharm Therapeutics Inc.
29 Feb 2024
EVP, Chief Development Officer
Sold at will
16,311
$19.08K
4.6%
KPTI Karyopharm Therapeutics Inc.
15 Feb 2024
EVP, Chief Development Officer
Sold at will
5,847
$7.78K
3.4%
KPTI Karyopharm Therapeutics Inc.
28 Jul 2023
EVP, Chief Development Officer
Sold on a plan
2,845
$4.84K
1.8%
KPTI Karyopharm Therapeutics Inc.
15 Feb 2023
EVP, Chief Development Officer
Sold, plan not stated
5,869
$18.72K
8.4%
14 decisions on file.